Trial
NCT02013778
Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
—
Condition
Hepatocellular Carcinoma
Intervention
HCQ
Why stopped
Lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-20